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18. Development of text mining tools for information retrieval and 
extraction from patents 
Tiago Alves, Hugo Costa and Miguel Rocha 
Biomedical literature is composed of a large and ever increasing 
number of publications, written in natural language. Patents are a 
relevant fraction of these publications, considered important sources 
of information due to all the curated information available in the 
documents, from the granting process. Although being real 
technological libraries, their unstructured data turns the search of 
information within these documents a challenging task. Biomedical 
text mining is a scientific field that explores this task, creating 
methodologies to search and structure the information in the 
biomedical literature.  
Information retrieval (IR) is one of the biomedical text mining tasks, in 
which the relevant information is obtained from an extensive 
collection of documents using several text retrieval methodologies. 
Getting all the information available on a patent document requires 
the download of all the bibliographic information as well as the 
respective patent PDF document, that is then converted into a 
machine-readable text by technologies as Optical Character 
Recognition (OCR).  
To achieve that goal, a “patent pipeline” was developed and 
integrated into @note2, an open-source computational framework for 
biomedical text mining. The patent pipeline can be disintegrated into 
four different tasks that were used to build different new processes on 
@note2: the patent search and the retrieval of patent metadata 
(relative to bibliographic data) were introduced as a new IR Search tool 
and the retrieval of patent PDF files as well as the subsequent 
 extraction of all the information from them were introduced as a new 
IR Crawling and a new PDF to text conversion processes, respectively.  
A set of patents from the BioCreative V CHEMDNER task was used to 
test the developed pipeline, evaluating the framework performance 
and the real capacity to retrieve the requested patents and extract 
their unstructured information to machine readable text. The results 
were promising, and showed that is possible bringing the published 
patent information to the scientific community, allowing the posterior 
implementation of other biomedical text mining processes over these 
documents, automating the search of structured information on 
patents and taking advantage of all the great informative capacity 
applied on them. 
 
19. Evidence for lineage-specific CD4+ T cell-driven diversifying 
selection in Mycobacterium tuberculosis pinpoints targets of co-
evolution with humans 
Carlos Magalhães, Iñaki Comas, Gil Castro, Jorge Pedrosa, Sebastien 
Gagneux, Margarida Saraiva and Nuno Osório 
Tuberculosis (TB), a devastating disease caused by bacteria from the 
Mycobacterium tuberculosis complex (MTBC), remains vastly 
uncontrolled. There is increasing evidence that the long parallel 
evolution of MTBC and the human host is in fact co-evolution. The 
precise identification of the molecular bases underlying immune-
related co-evolution is of major interest, as it may lay the foundations 
for novel and more effective TB vaccines. We investigated the 
existence of MTBC-varying CD4+ T cell epitopes by analyzing the 
diversity, evolution and immunogenicity of peptidic sequences 
encoded by 270 MTBC genomes. We found specific aminoacid 
residues that were predicted to be under diversifying selection and to 
induce large alterations in the number of encoded peptides with 
predicted high binding affinity to class II human leukocyte antigen 
(HLA) proteins. Overall, our findings highlight potential targets of co-
evolution that may have been selected to modulate host CD4+ T cell-
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